THERACLONE SCIENCES
Theraclone Sciences (formerly Spaltudaq) is a Seattle-based discovery-stage biotech focused on the development of novel therapeutic antibodies for the treatment of infectious disease and inflammation. The company's technology harnesses the power of the human immune system to identify naturally evolved monoclonal antibodies from the blood cells of immunologically relevant human subjects. Recombinant human monoclonal antibodies can be rapidly obtained using our discovery platform and scaled for la... rge-scale industrial production. Such antibody drug candidates may be uniquely important in combating disease and may have potential as therapeutic products that can be administered to a broad patient population. Theraclone is a privately held company with venture investment from ARCH Venture Partners, Canaan Partners, Healthcare Ventures, Amgen Ventures, MPM Capital, and Alexandria Real Estate Investment.
THERACLONE SCIENCES
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2004-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.theraclone-sciences.com
Total Employee:
11+
Status:
Active
Contact:
(206) 805-1600
Email Addresses:
[email protected]
Total Funding:
63.19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail
Similar Organizations
Abacus Bioscience
Abacus Bioscience specializes in developing immunotherapies for treating chronic infectious diseases and cancers.
Amakem
Amakem is a kinase platform company developing therapeutics for the treatment of serious eye conditions.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Connect Biopharmaceuticals
Connect Biopharma is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Emphasys Medical
Emphasys Medical develops therapeutic devices for the treatment of patients with emphysema and other breathing disorders.
Epicyte Pharmaceuticals
Epicyte Pharmaceutical is focused on development therapeutic monoclonal antibodies for cancer, infectious and inflammatory diseases.
Nereus Pharmaceuticals
Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.
Park Therapeutics
Park Therapeutics, a company developing a unique, first-in-class, investigational NCE for the treatment of pain which is Phase III-ready.
Sound Alignment
Sound Alignment is a web portal that enables vibration based therapeutics studies to be a remotely function via mobile devices.
Validus Cellular Therapeutics
Validus Cellular Therapeutics is a developer of therapeutic solutions for treating infectious diseases.
Wise Anderson Protocol
The Wise-Anderson Protocol was developed at Stanford University in the Department of Urology by David Wise, Ph.D. and Rodney Anderson M.D.
Current Advisors List
Current Employees Featured
Founder
Investors List
Amgen Ventures
Amgen Ventures investment in Series B - Theraclone Sciences
MidCap Financial
MidCap Financial investment in Debt Financing - Theraclone Sciences
MPM Capital
MPM Capital investment in Series B - Theraclone Sciences
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Theraclone Sciences
Versant Ventures
Versant Ventures investment in Series B - Theraclone Sciences
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Theraclone Sciences
Zenyaku Kogyo
Zenyaku Kogyo investment in Series B - Theraclone Sciences
Canaan Partners
Canaan Partners investment in Series B - Theraclone Sciences
Alexandria Real Estate Equities
Alexandria Real Estate Equities investment in Series B - Theraclone Sciences
HealthCare Ventures
HealthCare Ventures investment in Series B - Theraclone Sciences
Official Site Inspections
http://www.theraclone-sciences.com
- Host name: 55.245.178.68.host.secureserver.net
- IP address: 68.178.245.55
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
